Compare Maskapai Reasuransi Indonesia Tbk. (MREI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maskapai Reasuransi Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Maskapai Reasuransi Indonesia Tbk. trades at Rp920 (market cap 476.37B), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Maskapai Reasuransi Indonesia Tbk. is far larger — about 2.9× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.
| MREI | OBAT | |
|---|---|---|
Market Cap | 476.37B | 166.01B |
Volume | — | 324K |
Lot | — | 3.24K |
Turnover | — | 77.68M |
Average Price | — | 239.75 |
Value | — | 77.68M |
Indicative Equilibrium Price | — | 240 |
Indicative Equilibrium Volume | — | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Maskapai Reasuransi Indonesia Tbk.
PT Maskapai Reasuransi Indonesia Tbk (the Company) was established on 4th June 1953 based on Notarial Deed No. 15 of Anton Frederik Schut a substitute of Meester Karel Esuard Krijgsman, notary in Jakarta.In 1998 PT. Dharmala Sakti Sejahtera became one of Marein’s major shareholders, besides AJB Bumiputera 1912, and as the result the company was able to increase its paid up capital to Rp 3,002,500,000.
Read more on MREI →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
